BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 04/11/2013

FDA Clears INVEGA Extended-Release Tablet for Approval

The FDA has determined that INVEGA (paliperidone) extended-release tablet, 12 mg, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of the medication through abbreviated new drug applications.

Source: Federal Register — Food and Drug AdministrationOpen original release →